Combinatorial biomarkers to predict responses to immune checkpoint therapy in metastatic urothelial cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.6_suppl.488
Abstract: 488Background: Immune checkpoint therapy can produce durable anti-tumor responses in metastatic urothelial carcinoma (mUCC); however, the responses are not universal. Despite multiple approvals of ... read more here.
Keywords: immune checkpoint; checkpoint therapy; combinatorial biomarkers; metastatic urothelial ... See more keywords